Pharmaceutical Executive March 13, 2023
Meg Rivers

Judith Kulich, principal, patient health and equity lead, ZS, and Nan Gu, associate principal, patient health and equity, ZS, discuss health equity in pharma, specifically racial biases, and how the industry can address access and inequities going forward.

Health equity is a challenge for the bio/pharmaceutical industry. It is no secret that there are racial—and gender—biases within the pharmaceutical and healthcare industries, as is apparent through the types of treatments that are researched and developed as well as through the people and communities who have historically had access to and been included in clinical trials.

Pharmaceutical Executive interviews Judith Kulich, principal, patient health and equity lead, and Nan Gu, associate principal, patient health and equity, both of ZS (a...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Equity/SDOH, Healthcare System, Interview / Q&A, Pharma, Pharma / Biotech, Trends
Charted: Health (in)equity in the United States
Los Angeles is using AI in a pilot program to try to predict homelessness and allocate aid
Study: Disparities in access to in-network behavioral health care pervasive
Health disparities across states: 6 new findings
Racial health disparities exist in every state, new report says

Share This Article